A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Cancer is a serious health issue worldwide. Traditional treatment methods focus on killing cancer cells by using anticancer drugs or radiation therapy, but the cost of these methods is quite high, and in addition there are side effects. With the discovery of anticancer peptides, great progress has been made in cancer treatment. For the purpose of prompting the application of anticancer peptides in cancer treatment, it is necessary to use computational methods to identify anticancer peptides (ACPs). In this paper, we propose a sequence-based model for identifying ACPs (SAP). In our proposed SAP, the peptide is represented by 400D features or 400D features with g-gap dipeptide features, and then the unrelated features are pruned using the maximum relevance-maximum distance method. The experimental results demonstrate that our model performs better than some existing methods. Furthermore, our model has also been extended to other classifiers, and the performance is stable compared with some state-of-the-art works.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cd-hit: Accelerated for clustering the next-generation sequencing data
Fu, L., Niu, B., Zhu, Z., Wu, S., & Li, W. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts565 · Cited by 11,175
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
iRNA-PseU: Identifying RNA pseudouridine sites
Chen, W., Tang, H., Ye, J., Lin, H., & Chou, K.-C. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.37 · Cited by 291
Using subsite coupling to predict signal peptides
Chou, K.-C. (2001) · Protein Engineering, Design and Selection · doi:10.1093/protein/14.2.75 · Cited by 255
Wei, L., Xing, P., Zeng, J., Chen, J., Su, R., & Guo, F. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.03.001 · Cited by 242
Cited by
AntiCP 2.0: an updated model for predicting anticancer peptides
Agrawal, P., Bhagat, D., Mahalwal, M., Sharma, N., & Raghava, G. P. S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa153 · Cited by 345
Distance-based Support Vector Machine to Predict DNA N6- methyladenine Modification
Zhang, H., Zou, Q., Ju, Y., Song, C., & Chen, D. (2022) · Current Bioinformatics · doi:10.2174/1574893617666220404145517 · Cited by 316
Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Hwan Shin, T., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 312
An Efficient Classifier for Alzheimer’s Disease Genes Identification
Xu, L., Liang, G., Liao, C., Chen, G.-D., & Chang, C.-C. (2018) · Molecules · doi:10.3390/molecules23123140 · Cited by 107
Self-citationXuan, P., Sun, C., Zhang, T., Ye, Y., Shen, T., & Dong, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00459 · Cited by 100
Metadata
- Authors
- Xu, L., Liang, G., Wang, L., & Liao, C.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2018-03-13
- Volume
- 9
- Issue
- 3
- Pages
- 158
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2793278326
- Cited by
- 112
- References
- 5
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides. https://app.cochat.ai/papers/10.3390/genes9030158
- The paper
- Xu, L., Liang, G., Wang, L., & Liao, C. (2018). A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides. Genes. https://doi.org/10.3390/genes9030158
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.